Reading Time: 3 minutesA recent press release by the pharmaceutical company Biogen reported preliminary results from an ongoing clinical trial investigating a form of precision therapy in people
Category: Treatments
Reading Time: 10 minutes“The annals of ALS clinical trials is strewn with failed studies. Only two out of more than 70 clinical trials have been positive, and even
Reading Time: 7 minutesIs it possible that a drug that treats congestive heart failure could improve respiration in people with MND? Or that a drug used to treat
Reading Time: 7 minutesIn November 2018 the Home Office released a draft Guideline scope for Cannabis-based products for medicinal use in which they announced that specialist doctors (like
Reading Time: 5 minutesThere has recently been a flood of news stories on the outcomes of the Australian Phase 1 clinical trial investigating Copper ATSM (CuATSM) which is
Reading Time: 3 minutesThis blog is part of the ‘Highlights from Glasgow’ collection of articles, where you can read about the content of some of the talks and
Reading Time: 2 minutesThe research team frequently gets asked about the effectiveness of alternative therapies and their use as treatments for MND. Here we report on a recent
Reading Time: 7 minutesIn the last decade, the MND Association has invested millions in research within the UK and across the world. We are a leader in the
Reading Time: 2 minutesIn their official press release published on 21 November 2017, Cytokinetics Inc. announced that they will not be continuing work on tirasemtiv after disappointing results
Reading Time: 3 minutesAt last year’s Airlie House workshop to develop new ALS/MND Clinical Trial Guidelines the focus was, of course, on MND, but there was also important input